vs
Cellectis S.A.(CLLS)与RIVERVIEW BANCORP INC(RVSB)财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是Cellectis S.A.的1.5倍($14.0M vs $9.5M),RIVERVIEW BANCORP INC净利率更高(9.8% vs -265.9%,领先275.7%),Cellectis S.A.同比增速更快(375.0% vs 10.4%),Cellectis S.A.自由现金流更多($27.6M vs $-736.0K)
Cellectis S.A.是一家法国生物制药公司,专注于开发用于癌症免疫治疗的基因编辑嵌合抗原受体T细胞技术,目前在巴黎、纽约以及北卡罗来纳州罗利均设有办公机构,在肿瘤免疫基因编辑疗法领域拥有多年研发积累。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司,主营个人与商业银行业务,服务覆盖太平洋西北地区,提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品,服务零售客户与本地企业群体。
CLLS vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.5倍
$9.5M
营收增速更快
CLLS
高出364.6%
10.4%
净利率更高
RVSB
高出275.7%
-265.9%
自由现金流更多
CLLS
多$28.3M
$-736.0K
损益表 — Q2 FY2024 vs Q3 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $9.5M | $14.0M |
| 净利润 | $-25.3M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -181.1% | 12.4% |
| 净利率 | -265.9% | 9.8% |
| 营收同比 | 375.0% | 10.4% |
| 净利润同比 | -51.9% | 11.8% |
| 每股收益(稀释后) | $-0.28 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CLLS
RVSB
| Q4 25 | — | $14.0M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $13.3M | ||
| Q1 25 | — | $12.9M | ||
| Q4 24 | — | $12.7M | ||
| Q3 24 | — | $12.8M | ||
| Q2 24 | $9.5M | $12.2M | ||
| Q1 24 | — | $9.0M |
净利润
CLLS
RVSB
| Q4 25 | — | $1.4M | ||
| Q3 25 | — | $1.1M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $1.1M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $1.6M | ||
| Q2 24 | $-25.3M | $966.0K | ||
| Q1 24 | — | $-3.0M |
营业利润率
CLLS
RVSB
| Q4 25 | — | 12.4% | ||
| Q3 25 | — | 10.2% | ||
| Q2 25 | — | 11.7% | ||
| Q1 25 | — | 11.3% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 15.5% | ||
| Q2 24 | -181.1% | 10.0% | ||
| Q1 24 | — | -47.5% |
净利率
CLLS
RVSB
| Q4 25 | — | 9.8% | ||
| Q3 25 | — | 8.1% | ||
| Q2 25 | — | 9.2% | ||
| Q1 25 | — | 8.9% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | — | 12.2% | ||
| Q2 24 | -265.9% | 7.9% | ||
| Q1 24 | — | -34.7% |
每股收益(稀释后)
CLLS
RVSB
| Q4 25 | — | $0.07 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $0.05 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | — | $0.07 | ||
| Q2 24 | $-0.28 | $0.05 | ||
| Q1 24 | — | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $149.0M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $148.6M | $164.2M |
| 总资产 | $407.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CLLS
RVSB
| Q4 25 | — | $28.6M | ||
| Q3 25 | — | $32.8M | ||
| Q2 25 | — | $34.2M | ||
| Q1 25 | — | $29.4M | ||
| Q4 24 | — | $25.3M | ||
| Q3 24 | — | $31.0M | ||
| Q2 24 | $149.0M | $27.8M | ||
| Q1 24 | — | $23.6M |
股东权益
CLLS
RVSB
| Q4 25 | — | $164.2M | ||
| Q3 25 | — | $163.5M | ||
| Q2 25 | — | $162.0M | ||
| Q1 25 | — | $160.0M | ||
| Q4 24 | — | $158.3M | ||
| Q3 24 | — | $160.8M | ||
| Q2 24 | $148.6M | $155.9M | ||
| Q1 24 | — | $155.6M |
总资产
CLLS
RVSB
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $407.1M | $1.5B | ||
| Q1 24 | — | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $28.9M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $27.6M | $-736.0K |
| 自由现金流率自由现金流/营收 | 290.5% | -5.2% |
| 资本支出强度资本支出/营收 | 13.2% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势,按日历期对齐
经营现金流
CLLS
RVSB
| Q4 25 | — | $-506.0K | ||
| Q3 25 | — | $16.8M | ||
| Q2 25 | — | $-697.0K | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $764.0K | ||
| Q2 24 | $28.9M | $5.4M | ||
| Q1 24 | — | $12.8M |
自由现金流
CLLS
RVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $-773.0K | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | $27.6M | $5.3M | ||
| Q1 24 | — | $7.1M |
自由现金流率
CLLS
RVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | — | 120.1% | ||
| Q2 25 | — | -5.8% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 15.0% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | 290.5% | 43.7% | ||
| Q1 24 | — | 79.0% |
资本支出强度
CLLS
RVSB
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 21.0% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 17.3% | ||
| Q2 24 | 13.2% | 0.9% | ||
| Q1 24 | — | 62.0% |
现金转化率
CLLS
RVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图